Keyphrases
Attention Deficit Hyperactivity Disorder
100%
Positron Emission Tomography Study
66%
Dopamine Transporter
65%
Occupancy
38%
Long-acting Formulation
38%
Raclopride
33%
Dopaminergic Activity
33%
Armodafinil
33%
Childhood ADHD
33%
Deficient Emotional Self-regulation
33%
Oral Delivery System
33%
Dexmethylphenidate
33%
Oral Drug Absorption
33%
Control Subjects
33%
Pharmacokinetic Profile
33%
Short-acting
33%
Pharmacokinetics
33%
Response Potential
33%
Risk Analysis
33%
Absorption System
33%
Familial Risk
33%
Abuse Potential
33%
Risk Allele
33%
Disorder Control
33%
Receptor Occupancy
33%
C-11
33%
Child Behavior Checklist
33%
Spheroidal
33%
Methylphenidate
33%
Dopamine Transporter Binding
33%
Subjective Response
33%
Healthy Controls
33%
Controlled Release
33%
Functional Genomics
33%
Children with Attention Deficit
33%
Female Adolescents
33%
Psychoactive Substance Use
33%
3′-untranslated Region (3′-UTR)
27%
Extended-release Methylphenidate
23%
Psychiatric Comorbidity
22%
Structured Diagnostic Interview
18%
Proband
18%
Positron Emission Tomography
15%
Caudate
13%
Dopamine
13%
Central Nervous System
12%
Stimulants
12%
SLC6A3
12%
Limited Information
11%
Young Adulthood
11%
Neuroscience
Attention Deficit Hyperactivity Disorder
100%
Dopamine Transporter
56%
Positron Emission Tomography
35%
Armodafinil
33%
Dopaminergic Activity
33%
Functional Genomics
33%
Emotional Self-Regulation
33%
Child Behavior
33%
Raclopride
33%
Untranslated Region
23%
In Vivo
10%
Variable Number Tandem Repeat
7%
Wakefulness
6%
Drug Abuse
6%
Comorbidity
6%
Striatum
5%
DNA Polymorphism
5%
